Both in Pharmaceuticals
Merck & Co. vs Eli Lilly &
Over the past year MRK returned +81.3% and LLY returned +58.1%; their daily moves had a correlation of 0.44.
MRK +81.3% LLY +58.1%Growth of $1, one year, split-adjusted
| Metric | MRK | LLY |
|---|---|---|
| Price | $149.52 | $1,417.54 |
| Market cap | $368.89B | $1.26T |
| Today | +2.18% | +3.19% |
| 1 month | +4.0% | +23.3% |
| 6 months | +33.3% | +47.1% |
| Year to date | +42.0% | +31.9% |
| 1 year | +72.7% | +74.2% |
| Revenue growth (YoY) | +5.1% | +38.6% |
| Gross margin | 73.5% | 83.9% |
| Net margin | −8.0% | 26.4% |
| P/E (TTM) | 116.3× | 45.8× |
| Price / sales | 5.5× | 14.6× |
| Net cash | -$46.77B | -$44.62B |
| Dividend yield | 2.27% | 0.49% |
| Volatility (60d) | 36.0% | 30.8% |
| Short % of float | 1.1% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).